PMID: 9166391Jan 1, 1997Paper

Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years

Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
S AdamiM Passeri

Abstract

Two hundred and fifty-five postmenopausal women with distal forearm bone mineral density (BMD) 1 SD below the mean value for normal age-matched postmenopausal subjects were randomly allocated to a 2-year treatment with oral ipriflavone (200 mg t.i.d) or a matched placebo, according to a double-masked, parallel group design. All patients also received a 1 g/day calcium supplement. Distal radius BMD and bone metabolism markers were measured at baseline, and every 6 months. Blood haematology and chemistry and physical parameters were monitored at the same time. One hundred and ninety-six patients completed 2 years of treatment. BMD changes from baseline were analysed according to valid completers (VC) and intention to treat (ITT) analyses. In both cases radial BMD was maintained in patients treated with ipriflavone while in decrease in those receiving the placebo, the between-treatment difference being significant at year 1 and year 2. Urinary hydroxyproline/creatinine levels were decreased in the ipriflavone-treated group and increased in the placebo group, with a significant between-treatment difference. Adverse reactions, mainly gastrointestinal, occurred to a similar extent in the two treatment groups.

References

Dec 1, 1977·Annals of Internal Medicine·R R ReckerR P Heaney
Oct 1, 1992·Bone and Mineral·G MazzuoliS Minisola
Oct 1, 1992·Bone and Mineral·D AgnusdeiM Passeri
Nov 1, 1992·Journal of Endocrinological Investigation·G B MelisP Fioretti
Sep 1, 1991·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·S BenvenutiM L Brandi
Jan 27, 1990·BMJ : British Medical Journal·J N MatthewsP Royston
Jul 12, 1990·The New England Journal of Medicine·N B WattsM J Yanover
Sep 27, 1990·The New England Journal of Medicine·B Dawson-HughesS Tannenbaum
Mar 22, 1990·The New England Journal of Medicine·B L RiggsL J Melton
Mar 10, 1986·Life Sciences·I YamazakiM Kinoshita
Mar 1, 1995·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·S AdamiR Wasnich
Mar 1, 1995·Calcified Tissue International·R CivitelliA Dimarogonas
Nov 1, 1994·Calcified Tissue International·S L ChengR Civitelli
Jul 1, 1994·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·C HaslingL Mosekilde
Aug 1, 1994·Calcified Tissue International·K Overgaard, B J Riis
Mar 1, 1994·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·D ThiébaudC Gobelet
May 1, 1994·Calcified Tissue International·M ValenteL Zichella
Oct 1, 1993·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·L J MeltonB L Riggs
May 1, 1993·Journal of Endocrinological Investigation·M GambaccianiP Fioretti
Jan 1, 1993·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·C GennariA Camporeale
Jan 1, 1995·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·D AgnusdeiL Bufalino
Dec 1, 1996·Calcified Tissue International·C GhezzoS Bongrani
Jan 1, 1997·Calcified Tissue International·C GennariL Vecchiet

❮ Previous
Next ❯

Citations

Jan 1, 1997·Calcified Tissue International·J Y ReginsterC Roux
Jan 1, 1997·Calcified Tissue International·L V Avioli
Nov 26, 2002·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·H J KangM M Hammoud
Nov 15, 2000·Primary Care Update for Ob/Gyns·D Carusi
Jul 1, 1999·Environmental Toxicology and Pharmacology·M L Brandi
Jul 16, 2002·Current Opinion in Rheumatology·Diane M BiskobingRobert Downs
Mar 1, 2000·Clinical Obstetrics and Gynecology·B Kass-Annese
Oct 16, 2001·Clinical Obstetrics and Gynecology·C Tsourounis
Mar 17, 2001·Environmental Health Perspectives·P L Whitten, H B Patisaul
Jan 1, 1997·Calcified Tissue International·C GennariL Vecchiet
Apr 1, 2003·Expert Opinion on Investigational Drugs·Diane M Biskobing
Jan 17, 2007·Clinical Oral Implants Research·Koichi ItoShuichi Sato
Jan 7, 2014·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Juliana Macedo DelarmelinaMaria do Carmo Pimentel Batitucci
May 17, 2001·Menopause : the Journal of the North American Menopause Society·L J LuF L Bellino
Apr 27, 2005·Phytotherapy Research : PTR·Farzad DeyhimBahram H Arjmandi
Sep 22, 2000·The Journal of Clinical Endocrinology and Metabolism·K E WangenM S Kurzer
Jan 15, 1999·Journal of Medicinal Chemistry·M SatoC H Turner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.